Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth

Open Ended Schemes(Equity Scheme - Sectoral/ Thematic)Very High RiskISIN INF209KB1N91

NAV · 06-Jul-2026

₹35.4400

+7.44%

+14.17%

1Y (CAGR)

+14.63%

3Y (CAGR)

+22.95%

5Y (CAGR)

+13.11%

Since inception (CAGR)

+19.76%

NAV history

hover for values

Risk & SIP analytics

Q1 · TOP · 3Y in category

Volatility (3y)

12.97%

Downside dev (3y)

8.76%

Max drawdown (3y)

-16.3%

Sharpe (3y)

1.27

SIP XIRR (3y)

+16.21%

SIP XIRR (5y)

+18.19%

Calendar-year returns

2020 +53.8%2021 +19.5%2022 -12.7%2023 +37.7%2024 +35.8%2025 -4.3%

Fund facts

Fund managerDhaval Shah

AUM₹9,503 Cr

TER · AMFI officialDirect 1.01% · Regular 2.28% (2026-06-30)

Launch date20-Jun-2019

Plan typeOpen Ended · Equity

Min lumpsum1000

Lock-inNone

Volatility15.20

AMCAditya Birla Sun Life AMC Limited

Objective · The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes’ objectives will be achieved.

scheme documents ↗